Who is sponsoring NCT04310774?

NCT04310774 is sponsored by Peking Union Medical College Hospital.

What drugs are being tested in NCT04310774?

Interventions in NCT04310774: Tegafur, Gimeracil and Oteracil Potassium Capsules (one drug).

What condition does NCT04310774 study?

NCT04310774 studies Cervical Cancer, Chemotherapy.

Is NCT04310774 still recruiting?

NCT04310774 is currently status unknown. Last updated 19 March 2020.

Last reviewed 2020-03-19 · How we verify

NCT04310774

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

CCRT Followed by Tegafur, Gimeracil and Oteracil Potassium in Cervical Cancer

Status unknown Phase 1, PHASE2 Last updated 19 March 2020

What this trial tests

Phase 1, PHASE2 trial testing Tegafur, Gimeracil and Oteracil Potassium Capsules (one drug) in Cervical Cancer in 200 participants. Status unknown.

Timeline

15 April 2020

Primary endpoint
15 April 2024

15 April 2026

Quick facts

Lead sponsor	Peking Union Medical College Hospital
Phase	Phase 1, PHASE2
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	200
Start date	15 April 2020
Primary completion	15 April 2024
Estimated completion	15 April 2026

Drugs / interventions tested

Tegafur, Gimeracil and Oteracil Potassium Capsules (one drug) — full drug profile →

Conditions studied

Cervical Cancer — all drugs for Cervical Cancer →
Chemotherapy — all drugs for Chemotherapy →

Sponsor

Peking Union Medical College Hospital

Who can join

Adults 18 to 70, female only, with Cervical Cancer or Chemotherapy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a single institute, single-arm, interventional trial to evaluate the efficacy and toxicity of concurrent chemoradiotherapy (CCRT) followed by Tegafur, Gimeracil and Oteracil Potassium Capsules consolidation chemotherapy in patients with locally advanced cervical cancer.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

The oncogenic control of nucleotide synthesis.
Vidal-Cruchez O, Ben-Sahra I. · · 2026 · PMID 41881963 · DOI 10.1038/s41389-026-00608-2

Verify or expand the search:

Other recruiting trials for Cervical Cancer

Currently open trials in the same condition.

NCT07276360 — Hypofractionated Radiotherapy for the Treatment of Locally Advanced Cervical Cancer in Uganda · Phase 2 · recruiting
NCT05570422 — A Study to Evaluate the Safety, Tolerability, Preliminary Efficacy of KRC-01 · Phase 1 · recruiting
NCT07225530 — Implementation of Screen, Treat, and Triage for Women Living With HIV in La Romana (iSTAR) · NA · recruiting
NCT07209917 — Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India · NA · recruiting
NCT07256236 — SKB264 Plus QL1706 in Recurrent or Metastatic Cervical Cancer · Phase 2 · recruiting

Other Peking Union Medical College Hospital trials

Trials by the same sponsor.

NCT07466251 — PCSK9 Inhibitor for Intracranial Atherosclerosis Related Acute Ischemic Stroke · Phase 4 · not yet recruiting
NCT06743321 — Speech-to-speech Voice-cloning Care (SVCC) to Improve ICU-acquired Anxiety for Critically Ill Patients · NA · not yet recruiting
NCT07590336 — 68Ga-NYM207 PET/CT Imaging in Hepatocellular Carcinoma · Phase 1, PHASE2 · not yet recruiting
NCT07515976 — Mapping of Genomic Structural Variations in Major Birth Defects · not yet recruiting
NCT07386756 — Early Precise Identification and Intervention Strategies for Individuals at High Risk of Prediabetes · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04310774 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Peking Union Medical College Hospital
Last refreshed: 19 March 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04310774.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing